Christina Schlegl

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Immune Response

Ejection Fraction

Circulating Tumor

Coronary Artery Disease

Top Venues

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jiayu Cao, Stefan Roth, Sijia Zhang, Anna Kopczak, Samira Mami, Yaw Asare, Marios K Georgakis, Denise Messerer, Amit Horn, Ruth Shemer, Charlene Jacqmarcq, Audrey Picot, Jack P Green, Christina Schlegl, Xinghai Li, Lukas Tomas, Alexander Dutsch, Thomas G Liman, Matthias Endres, Saskia R Wernsdorf, Christina Fürle, Olga Carofiglio, Jie Zhu, David Brough, null null, Veit Hornung, Martin Dichgans, Denis Vivien, Christian Schulz, Yuval Dor, Steffen Tiedt, Hendrik B Sager, Gerrit Maximilian Grosse, Arthur Liesz
DNA-sensing inflammasomes cause recurrent atherosclerotic stroke. Nature (2024)
Jiayu Cao, Stefan Roth, Sijia Zhang, Anna Kopczak, Samira Mami, Yaw Asare, Marios K Georgakis, Denise Messerer, Amit Horn, Ruth Shemer, Charlene Jacqmarcq, Audrey Picot, Jack P Green, Christina Schlegl, Xinghai Li, Lukas Tomas, Alexander Dutsch, Thomas G Liman, Matthias Endres, Saskia R Wernsdorf, Christina Fürle, Olga Carofiglio, Jie Zhu, David Brough, null null, Veit Hornung, Martin Dichgans, Denis Vivien, Christian Schulz, Yuval Dor, Steffen Tiedt, Hendrik B Sager, Gerrit Maximilian Grosse, Arthur Liesz
DNA-sensing inflammasomes cause recurrent atherosclerotic stroke. Nature (2024)
Yaw Asare, Margarita Shnipova, Luka Živković, Christina Schlegl, Federica Tosato, Arailym Aronova, Markus Brandhofer, Laura Strohm, Nathalie Beaufort, Rainer Malik, Christian Weber, Jürgen Bernhagen, Martin Dichgans
IKKβ binds NLRP3 providing a shortcut to inflammasome activation for rapid immune responses. Signal transduction and targeted therapy 7 (1) (2022)